scPharmaceuticals Inc. (SCPH) Social Stream
SCPHARMACEUTICALS INC (SCPH) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SCPH.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-16 | 3 | $15 | $6 | $10.666 | $6.28 | 69.84% |
| 2022-03-23 | 3 | $15 | $5 | $10.333 | $6.28 | 64.54% |
| 2022-05-17 | 2 | $15 | $6 | $10.5 | $6.28 | 67.2% |
| 2022-10-03 | 3 | $15 | $6 | $10.333 | $6.28 | 64.54% |
| 2022-10-14 | 3 | $15 | $11 | $13 | $6.28 | 107.01% |
| 2022-10-28 | 4 | $15 | $11 | $13.25 | $6.28 | 110.99% |
| 2022-11-28 | 4 | $18 | $12 | $14.25 | $6.28 | 126.91% |
| 2022-12-02 | 5 | $25 | $12 | $16.4 | $6.28 | 161.15% |
| 2023-02-22 | 5 | $25 | $13 | $16.6 | $6.28 | 164.33% |
| 2023-03-23 | 5 | $18 | $13 | $14.75 | $6.28 | 134.87% |
| 2023-03-24 | 5 | $25 | $13 | $16.8 | $6.28 | 167.52% |
| 2023-04-24 | 5 | $25.001 | $13 | $16.8 | $6.28 | 167.52% |
| 2023-05-11 | 5 | $25.001 | $13 | $17.4 | $6.28 | 177.07% |
| 2023-05-15 | 5 | $25 | $14 | $18.8 | $6.28 | 199.36% |
| 2023-08-14 | 5 | $25 | $16 | $19.2 | $6.28 | 205.73% |
| 2023-11-13 | 6 | $25 | $16 | $19.333 | $6.28 | 207.85% |
The Trend in the Analyst Price Target
SCPH's average price target has moved up $5.08 over the prior 12 months.
SCPH reports an average of 125.56% for its upside potential over the past 41 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-24 | 5 | 25.001 | 13 | 16.8 | 10.16 | 65.35% |
| 2023-05-02 | 5 | 25.001 | 13 | 17.4 | 10.58 | 64.46% |
| 2023-05-11 | 5 | 25.001 | 13 | 17.4 | 11.20 | 55.36% |
| 2023-05-15 | 5 | 25.000 | 14 | 18.8 | 11.53 | 63.05% |
| 2023-07-19 | 5 | 25.000 | 16 | 19.2 | 8.35 | 129.94% |
SCPH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 6 | 0 | 0 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 13 months, SCPH's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- SCPHARMACEUTICALS INC's number of analysts covering the stock is higher than 284.6% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, SCPHARMACEUTICALS INC's average analyst price target is greater than 336.65% of them.
- In terms of how SCPHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1613.74% of that group.
- In the context of stocks in the small market cap category, SCPHARMACEUTICALS INC's variance in analysts' estimates is lower than -1218.93% of them.
In the Pharmaceutical Products industry, KALA, ATHE, and VRNA are the three stocks most similar to SCPHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is SCPH a Buy, Hold or Sell? See the POWR Ratings now!